布鲁克推出高性价比的microflex LT MALDI-TOF用于常规的多肽和蛋白分析

2005年Pittcon会议           

Bruker Daltonics Introduces Affordable microflex LT MALDI-TOF for Routine Peptide and Protein Analysis.

ORLANDO, Fla. --At Pittcon 2005, Bruker Daltonics Inc., an operating company of Bruker BioSciences Corporation (NASDAQ: BRKR), today announces the microflex(TM) LT, an affordable, bench-top MALDI-TOF mass spectrometer for clinical proteomics, as well as for the routine analysis of peptides, proteins and other large molecules.

Due to its gridless ion source, this new instrument provides excellent sensitivity in both positive and negative ion mode. The linear-mode microflex LT is a robust and easy-to-use system for many clinical and life-science laboratories. It operates under the integrated Compass(TM) software for intuitive operation by non-expert users and in multi-instrument laboratories, with a comprehensive bioinformatics software suite.

The microflex LT benefits from Bruker Daltonics" patented AnchorChip(TM) technology which provides exactly-positioned samples on the MALDI-target for robust automatic measurements, as well as a sensitivity boost by up to two orders of magnitude.

The microflex LT system can be an integral module of the ClinProt(TM) solution for biomarker discovery and clinical proteomics. ClinProt is an integrated set of tools for peptide and protein biomarker discovery, identification and validation, including automated magnetic bead based sample preparation methods, and ClinProTools(TM) comprehensive analysis, visualization and model building software for clinical research.

For pharmaceutical customers, the microflex LT system offers software tools to support customers in achieving 21 CFR Part 11 compliance. Bruker Daltonics also offers optional IQ, OQ and PV services to FDA-regulated customers.

Dr. Ulli Giessman, Vice President of Bruker Daltonics, explains: "With the microflex LT, we have further expanded our industry-leading FLEX-series of MALDI-TOF systems. The microflex LT is a modern, high-quality system that will appeal particularly to clinical researchers, pharmaceutical customers as well as smaller universities and colleges."

Pittcon 2005, the 56th Pittsburgh Conference and Exposition on Analytical Chemistry and Applied Spectroscopy, is being held from February 27 through March 4 in the Orange County Convention Center. The product introduced here will be exhibited at the Bruker booth #3176.

ABOUT BRUKER BIOSCIENCES

Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker AXS Inc. and Bruker Daltonics Inc. Bruker AXS is a leading developer and provider of life science and advanced materials research tools based on X-ray technology. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. Bruker Daltonics also offers a broad line of nuclear, biological and chemical (NBC) detection products for defense and homeland security. For more information, please visit www.bruker-biosciences.com